China's SFDA Plans To Release New GMP Guidelines In June To Bring Chinese Pharmas To Global Stage: CPhI China Conference
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - While more than 8 million people have visited the World Expo in Shanghai, more than 1,600 pharma, biotech and active pharmaceutical ingredient providers in China are also gathering in Shanghai for the Expo CPhI
You may also be interested in...
China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines
SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China
China One Step Closer To Global Standards For Drug Quality With Rollout Of New GMP Guidelines
SHANGHAI - China's State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China
China Adds CTD and DMF Filing Requirements to Enhance Drug Quality
SHANGHAI – China’s State FDA recently issued a note to provincial FDA offices to require pharma companies and active pharmaceutical ingredient producers to file a Common Technical Document when they submit manufacturing applications as an effort to improve drug quality and research and development work in China.